Close Menu

Texas Children's Cancer Center

Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.

The new Pediatric Center for Personal Cancer Genomics and Therapeutics plans to routinely sequence every new patient that comes into the Texas Children's Cancer Center and hopes eventually to begin sequencing all new pediatric cancer cases in the state of Texas.

BCM has started a new pediatric cancer research center that will use clinical tumor sequencing for research and to develop treatments.

The Doris Duke Charitable Foundation has given a nearly $500,000 grant to the Texas Children's Cancer Center and Baylor to identify glioma-causing genetic mutations.

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.